| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.27B | 23.27B | 22.13B | 22.05B | 20.35B | 17.82B |
| Gross Profit | 7.70B | 7.70B | 6.64B | 6.44B | 5.93B | 5.55B |
| EBITDA | 6.16B | 6.08B | 5.11B | 4.79B | 4.44B | 4.05B |
| Net Income | 3.64B | 3.64B | 2.95B | 2.69B | 2.36B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 36.11B | 36.11B | 32.00B | 28.46B | 26.25B | 24.80B |
| Cash, Cash Equivalents and Short-Term Investments | 14.92B | 14.92B | 13.95B | 10.77B | 9.12B | 8.26B |
| Total Debt | 2.45B | 2.45B | 2.83B | 3.14B | 3.49B | 3.87B |
| Total Liabilities | 7.99B | 7.99B | 6.95B | 7.54B | 7.58B | 8.10B |
| Stockholders Equity | 28.12B | 28.12B | 25.05B | 20.92B | 18.67B | 16.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.89B | 2.39B | 2.47B | 1.65B | 2.85B |
| Operating Cash Flow | 0.00 | 3.78B | 3.83B | 2.74B | 2.09B | 3.05B |
| Investing Cash Flow | 0.00 | -1.28B | -1.47B | -304.11M | -477.33M | -223.29M |
| Financing Cash Flow | 0.00 | -938.67M | 795.25M | -812.06M | -804.93M | -678.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥33.76B | 12.01 | ― | 6.29% | -12.03% | -19.61% | |
77 Outperform | ¥36.64B | 9.81 | ― | 1.92% | 13.37% | 19.73% | |
71 Outperform | ¥46.70B | 15.55 | 6.49% | 2.39% | 12.01% | -51.38% | |
63 Neutral | ¥41.01B | 20.74 | ― | 2.75% | 7.56% | -48.91% | |
60 Neutral | ¥20.78B | -5.07 | ― | 3.71% | 7.50% | -281.41% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | ¥19.79B | -10.52 | ― | 3.65% | 9.53% | -155.76% |
Koa Shoji Holdings Co., Ltd. reported a strong financial performance for the first quarter of the fiscal year ending June 2026, with sales increasing by 18.4% and operating profit rising by 20.1% year-on-year. This growth was driven by a recovery in existing API products and robust sales from the Zao Factory. However, the company faced challenges such as a decline in sales from the HQ Factory due to increased competition and a foreign exchange loss. The impact of U.S. policies on the company’s performance was minimal due to its domestic focus. Additionally, there is a proposal to increase the number of stable supply pharmaceuticals, indicating a need for strengthening the supply system.
The most recent analyst rating on (JP:9273) stock is a Buy with a Yen875.00 price target. To see the full list of analyst forecasts on Koa Shoji Holdings Co., Ltd. stock, see the JP:9273 Stock Forecast page.
Koa Shoji Holdings Co., Ltd. reported a significant increase in its financial performance for the three months ended September 30, 2025, with net sales rising by 18.4% and operating profit increasing by 20.1% compared to the previous year. The company’s strong financial results indicate a positive impact on its operations and suggest a solid market positioning, which could be beneficial for stakeholders.
The most recent analyst rating on (JP:9273) stock is a Buy with a Yen875.00 price target. To see the full list of analyst forecasts on Koa Shoji Holdings Co., Ltd. stock, see the JP:9273 Stock Forecast page.